副腎皮質ホルモンAPI市場レポート：動向、予測、競合分析 (2031年まで)

世界の副腎皮質ホルモンAPI市場の将来は、注射薬、経口薬、外用薬、吸入薬市場に機会がありそうです。世界の副腎皮質ホルモンAPI市場は、2025年から2031年にかけてCAGR 5.9％で成長すると予想されます。この市場の主な促進要因は、ホルモン補充療法の需要拡大と副腎不全疾患の有病率の上昇です。

• Lucintel社の予測によると、種類別ではプレドニゾンシリーズが予測期間中に最も高い成長を遂げる見込みです。
• 用途別では、注射剤が最も高い成長が見込まれます。
• 地域別では、北米が予測期間中に最も高い成長が見込まれます。

副腎皮質ホルモンAPI市場の戦略的成長機会

副腎皮質ホルモンAPI市場には、主要用途に関連する戦略的成長機会がいくつか存在します。これは、急速な技術革新、標的治療に対する新たな需要、マーケットプレースにおけるニーズの拡大に起因しています。

• 慢性副腎不全治療への適用：慢性副腎不全の全体的な有病率は、副腎皮質ホルモンAPIに大きな機会をもたらしています。患者のニーズを満たし、この疾患に関する治療成績を向上させることができる高度な治療法や改良型製剤の開発が必要とされています。
• 腫瘍学における利用：副腎皮質ホルモンは、がん治療の中でも、がんの症状管理のための治療に応用されています。このような用途や標的療法に関する調査の進展は、腫瘍学市場に新たな機会をもたらすであろう。
• 自己免疫疾患の管理：アジソン病や関節リウマチなどの自己免疫疾患の管理におけるホルモン療法の必要性の高まりは、この治療分野における特殊な副腎皮質ホルモンAPIの開発機会を創出します。
• 個別化副腎皮質ホルモン療法：個別化医療は、カスタマイズされた副腎皮質ホルモン療法を提供するユニークな機会を提供します。このような治療法は患者プロファイルに従って処方され、より優れた有効性と副作用の少なさを提供するため、個別化医療ソリューションの需要に応えることができます。
• 新興市場の拡大：新興国市場は副腎皮質ホルモンAPIにとって有望な開発機会を提供します。これらの地域に進出することで、新たな顧客を獲得し、医療インフラを強化し、ホルモンを含む効果的な治療に対する需要の高まりに応えることができます。

副腎皮質ホルモンAPI市場では、慢性副腎不全の治療、腫瘍学への応用、自己免疫疾患の管理、個別化ホルモン療法、新興市場などが戦略的成長機会となります。このような機会は、事業拡大、技術革新、医療ニーズや動向とのより良い一致への道を開くと思われます。

副腎皮質ホルモンAPI市場の促進要因・課題

副腎皮質ホルモンAPI市場では、様々な要因が市場促進要因として作用する一方、技術的要因・経済的要因・規制上の考慮事項などの課題がこれらのバランスを取ることになります。明確な理解は、市場を効果的にナビゲートするのに役立ちます。

副腎皮質ホルモンAPI市場の促進要因には以下のようなものがあります：

• 技術の進歩：合成法や製剤技術の進歩など、ホルモン原薬の生産に関連する技術の革新的開拓は、製品の品質と有効性を高め、市場の成長を促進します。これらの開発は、副腎皮質ホルモンに関連する新しい治療法や改善された治療法の開発をサポートします。
• 標的治療に対する需要の増加：標的療法や個別化療法の需要の増加は、標的副腎皮質ホルモンAPIの需要増加の根拠となります。この需要により、さまざまな集団や病態を対象とした技術革新が促進され、市場の成長が加速します。
• ホルモン障害の有病率の増加：副腎不全や自己免疫疾患などのホルモン疾患の有病率の増加は、副腎皮質ホルモンAPIの需要を促進しています。これらの疾患を効果的な製剤で治療することは、市場の成長に大きく寄与します。
• 研究開発への投資：研究開発投資の増加は副腎皮質ホルモンAPIの進歩を支えています。研究開発は、新しい製剤の開発、既存の治療法の強化、他の適応症の特定に重点を置いています。
• イノベーションを支援する規制の枠組み：新規副腎皮質ホルモンAPIを承認するための支援的な規制環境と合理化された手続きは、市場参入を促進します。製品の安全性を確保しつつ承認を迅速化するための規制機関関連の活動は、市場の成長に寄与しています。

副腎皮質ホルモンAPI市場における課題は以下の通りです：

• 規制の複雑さ：複雑な規制要件と絶えず変化するコンプライアンス基準が大きな課題となっています。安全性と有効性の基準を満たすために必要な規制に関する知識とプロセスは、費用と時間がかかるが、市場承認には不可欠な投資です。
• 高い製造コスト：高コストの副腎皮質ホルモンAPIの製造には、高価な原材料と高度な技術が必要とされることが多いです。製品の品質を確保しながら製造コストをコントロールすることは極めて重要です。
• サプライチェーンの混乱：サプライチェーンの混乱は、ホルモン原薬の入手可能性と価格に影響を及ぼす原材料の不足や物流の問題を引き起こす可能性があります。したがって、弾力性を確保し、こうした課題を軽減するサプライチェーン戦略の策定が不可欠です。

副腎皮質ホルモンAPI市場の主な促進要因としては、技術の進歩、標的治療に対する需要の増加、ホルモン疾患の有病率の上昇、研究開発への投資、規制当局の支援などが挙げられます。さらに、成功を収めるためには、規制上のハードルを克服し、高い生産コストを管理し、サプライチェーンの混乱に対処することが重要な課題です。

目次

第1章 エグゼクティブサマリー

第2章 世界の副腎皮質ホルモンAPI市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界の副腎皮質ホルモンAPI市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界の副腎皮質ホルモンAPI市場：種類別
  • プレドニゾンシリーズ
  • デキサメタゾンシリーズ
  • ベタメタゾンシリーズ
  • ヒドロコルチゾンシリーズ
  • その他
• 世界の副腎皮質ホルモンAPI市場：用途別
  • 注射薬
  • 経口薬
  • 外用薬
  • 吸入薬

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界の副腎皮質ホルモンAPI市場：地域別
• 北米の副腎皮質ホルモンAPI市場
• 欧州の副腎皮質ホルモンAPI市場
• アジア太平洋の副腎皮質ホルモンAPI市場
• その他地域の副腎皮質ホルモンAPI市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界の副腎皮質ホルモンAPI市場の成長機会：種類別
  • 世界の副腎皮質ホルモンAPI市場の成長機会：用途別
  • 世界の副腎皮質ホルモンAPI市場の成長機会：地域別
• 世界の副腎皮質ホルモンAPI市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の副腎皮質ホルモンAPI市場の生産能力拡大
  • 世界の副腎皮質ホルモンAPI市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Pfizer CentreOne
• EuroAPI
• GlaxoSmithKline
• Teva Pharmaceutical Industries
• Hovione
• Axplora
• Steroid Spa
• Avik Pharmaceutical
• Anuh Pharma
• Symbiotec Pharmalab

The future of the global adrenocortical hormone API market looks promising with opportunities in the injectable drug, oral drug, for external use drug, and inhalation drug markets. The global adrenocortical hormone API market is expected to grow with a CAGR of 5.9% from 2025 to 2031. The major drivers for this market are the growing demand for hormonal replacement therapies and rising prevalence of adrenal insufficiency disorders.

• Lucintel forecasts that, within the type category, the prednisone series is expected to witness the highest growth over the forecast period.
• Within the application category, the injectable drug is expected to witness the highest growth.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Adrenocortical Hormone API Market

Indeed, several emerging trends have pushed the growth of the adrenocortical hormone API market due to technological advancement, changes in regulation, and a shift in demand within the market. These current trends affect the development, production, and distribution of adrenocortical hormone APIs.

• Advancement in Drug Delivery Systems: New delivery systems for drugs, including extended-release and targeted methods of delivery, are part of the developments that make adrenocortical hormones more effective. This provides better patient compliance because these hormones can now be released in a better-controlled and more sustained way, improving therapeutic results.
• Personalized Medicine: Personalized medicine is generating growing interest in the adrenocortical hormone market. Such therapies, tailored to individual genetic profiles and specific disease conditions, will be more efficient and focused, thus promising better results for patients with fewer side effects.
• Production Capacity Expansion: Pharmaceutical firms are investing in the expansion of their manufacturing capacities to meet growing global demand. Upgrading facilities and adopting advanced technology at the manufacturing site assists companies in maintaining product quality and availability in the market.
• Regulatory Enhancements and Compliance: Regulatory bodies are implementing stricter guidelines and standards for the manufacture of hormone APIs. Companies are focusing on achieving compliance with enhanced regulations to ensure customer safety and market approval in various regions.
• Growing Research and Development Efforts: Increased R&D efforts are among the leading factors ensuring innovation in adrenocortical hormone APIs. Research focuses on new formulations, improvements of existing therapies, and finding novel applications of hormone APIs across different therapeutic fields.

Trends such as the development of drug delivery systems, personalized medicine, increased production capacity, regulatory improvements, and extensive R&D are transforming the adrenocortical hormone API market. Thus, these trends are driving innovation, optimizing product offerings by responding to new market needs and adapting to changing regulatory requirements.

Recent Developments in the Adrenocortical Hormone API Market

The developing pattern in the adrenocortical hormone API market is influenced by changing technological scales, regulatory frameworks, and market demands. The future and growth of the market are marked by new developments.

• Innovation in Formulation Technologies: Advances in formulation technologies are resulting in increased potency and stability of adrenocortical hormone APIs. Some of the new formulations include nanoparticle-based delivery systems that improve the bioavailability of hormones and their therapeutic use.
• Regulatory Approvals for New Products: The number of regulatory approvals now allows a wider range of therapeutic options for several new adrenocortical hormone APIs. These approvals enable companies to introduce innovative products to address unmet medical needs in hormone therapy.
• Increased Investment in Biotech Startups: Investments in biotech startups specializing in the production of adrenocortical hormones are growing. The development of new hormone active pharmaceutical ingredients and innovative delivery methods improves market growth prospects and competitiveness.
• Technological Upgrades in Manufacturing: One of the most important areas of visible technological advancement is in manufacturing technologies. Companies are investing more in automation, real-time monitoring, and quality control to establish consistency and reliability in production processes.
• Emerging Market Expansion: The API market for adrenocortical hormone development is expanding in emerging markets due to high demand and better healthcare infrastructure. Companies are establishing their presence in these regions to capitalize on growth opportunities and meet local market demands.

In general, key developments in innovation in formulation technologies, regulatory approvals, increased investment in biotech startups, technological upgrades in manufacturing, and penetration into emerging markets act as growth drivers in the adrenocortical hormone API market. These developments offer opportunities for value addition to product offerings and streamlining of the manufacturing process while presenting new markets.

Strategic Growth Opportunities for the Adrenocortical Hormone API Market

There are several strategic growth opportunities related to key applications in the adrenocortical hormone API market. This is attributed to rapid technological changes, emerging demand for targeted therapies, and expanding needs in the marketplace.

• Application in Chronic Adrenal Insufficiency Treatments: The overall prevalence of chronic adrenal insufficiency presents a significant opportunity for adrenocortical hormone APIs. There is a need for developing advanced treatments and improved formulations that can meet patient needs and improve therapeutic outcomes related to the condition.
• Applications in Oncology: Adrenocortical hormones are applied in treatments for symptom management of cancers, among other oncology treatments. Growing research on these applications and targeted therapies will open up new opportunities in the oncology market.
• Managing Autoimmune Diseases: The growing need for hormone therapies in managing autoimmune diseases such as Addison's disease and rheumatoid arthritis creates opportunities for developing specialized adrenocortical hormone APIs in this therapeutic segment.
• Personalized Adrenocortical Hormone Therapies: Personalized medicine offers a unique opportunity to provide customized adrenocortical hormone therapies. These therapies would be prescribed according to a patient profile, offering better efficacy and fewer side effects, thus responding to a demand for personalized healthcare solutions.
• Emerging Market Expansion: Emerging markets provide promising development opportunities for adrenocortical hormone APIs. Expanding into these regions will attract new customers, increase healthcare infrastructure, and meet the growing demand for effective treatments that include hormones.

In the adrenocortical hormone API market, strategic growth opportunities will encompass treatments for chronic adrenal insufficiency, applications in oncology, management of autoimmune diseases, personalized hormone therapies, and emerging markets. Such opportunities will pave the way for business expansion, innovation, and better alignment with healthcare needs and trends.

Adrenocortical Hormone API Market Driver and Challenges

Various factors act as drivers in the adrenocortical hormone API market, while challenges such as technological, economic factors, and regulatory considerations will balance these. A clear understanding will assist in navigating the market effectively.

The factors responsible for driving the adrenocortical hormone API market include:

• Technological Advancement: Innovative developments in technologies related to the production of hormone APIs, including advancements in synthesis methods and formulation technologies, enhance product quality and effectiveness, thus driving market growth. These advancements support the development of new and improved therapies related to adrenocortical hormones.
• Increasing Demand for Targeted Therapies: Growth in demand for targeted and personalized therapies creates a rationale for increased demand for targeted adrenocortical hormone APIs. This demand drives innovation aimed at different populations and disease states, accelerating market growth.
• Growing Prevalence of Hormonal Disorders: The growing prevalence of hormonal disorders, including adrenal insufficiency and autoimmune diseases, fuels demand for adrenocortical hormone APIs. Treating these conditions with effective formulations contributes significantly to market growth.
• Investment in R&D: Increasing research and development investments support the advancement of adrenocortical hormone APIs. R&D focuses on developing new formulations, enhancing existing therapies, and identifying other indications.
• Supportive Regulatory Framework for Innovation: Supportive regulatory environments and streamlined procedures for approving new adrenocortical hormone APIs facilitate market access. Activities related to regulatory bodies to expedite approvals while ensuring product safety contribute to market growth.

Challenges in the adrenocortical hormone API market include:

• Regulatory Complexity: Complex regulatory requirements and ever-changing compliance standards pose significant challenges. The regulatory knowledge and processes needed to meet safety and efficacy standards are expensive and time-consuming but are essential investments for market approval.
• High Cost of Production: The production of high-cost adrenocortical hormone APIs often involves expensive raw materials and sophisticated technologies. Controlling production costs while ensuring product quality is crucial.
• Disruption of Supply Chains: Disruptions of supply chains may result in raw material shortages or logistical issues that affect the availability and price of hormone APIs. Therefore, it is essential to develop supply chain strategies that ensure resilience and mitigate these challenges.

The main driving factors in the adrenocortical hormone API market include technological advancement, increasing demand for targeted therapies, rising prevalence of hormonal disorders, investments in R&D, and regulatory support. Additionally, to achieve success, overcoming regulatory hurdles, managing high production costs, and addressing supply chain disruptions are critical challenges.

List of Adrenocortical Hormone API Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, adrenocortical hormone API companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the adrenocortical hormone API companies profiled in this report include-

• Pfizer CentreOne
• EuroAPI
• GlaxoSmithKline
• Teva Pharmaceutical Industries
• Hovione
• Axplora
• Steroid Spa
• Avik Pharmaceutical
• Anuh Pharma
• Symbiotec Pharmalab

Adrenocortical Hormone API by Segment

The study includes a forecast for the global adrenocortical hormone API market by type, application, and region.

Adrenocortical Hormone API Market by Type [Analysis by Value from 2019 to 2031]:

• Prednisone Series
• Dexamethasone Series
• Betamethasone Series
• Hydrocortisone Series
• Others

Adrenocortical Hormone API Market by Application [Analysis by Value from 2019 to 2031]:

• Injectable Drug
• Oral Drug
• For External Use Drug
• Inhalation Drug

Adrenocortical Hormone API Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Adrenocortical Hormone API Market

The adrenocortical hormone API market represents an evolving domain, with various key recent developments driven by advances in pharmaceutical research, regulatory changes, and further growth in demand for effective treatments. The market typically consists of hormones such as cortisol and aldosterone and is experiencing changes in different regions.

• United States: New developments involve higher investments in research and development of new formulations and delivery systems for adrenocortical hormones. This aims to enhance the efficacy and safety profiles of these APIs. Several biotech firms are advancing their clinical trials for new treatments targeting disorders of the adrenal gland.
• China: Improvements in manufacturing technologies are expanding the adrenocortical hormone API market in China. Local companies are increasing production to meet emerging demand due to rising domestic and international consumption. Additionally, the growing trend of Chinese pharmaceutical companies collaborating with global firms facilitates the development of new hormone APIs and formulations.
• Germany: The German market is experiencing changes in compliance perspectives and quality assurance processes. German pharmaceutical companies are enhancing their production cycles by introducing new technologies that improve consistency in the production of adrenocortical hormone APIs. Furthermore, the country aims to boost export volumes to meet European and global demand.
• India: The current era is witnessing growth in the adrenocortical hormone API sector. Factors contributing to this include increased investments in infrastructure and technology. Manufacturers in India seek to enhance their processes to meet international standards of product quality. They are also focusing on research and development of cost-effective hormone APIs to satisfy domestic and global market demands.
• Japan: Japan is concentrating on new formulations of adrenocortical hormone APIs and precision medicine. Japanese companies are investing in advanced research for targeted therapies and better delivery mechanisms. The country is also emphasizing partnerships with international companies to expand market exposure and develop superior products.

Features of the Global Adrenocortical Hormone API Market

Market Size Estimates: Adrenocortical hormone API market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Adrenocortical hormone API market size by type, application, and region in terms of value ($B).

Regional Analysis: Adrenocortical hormone API market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the adrenocortical hormone API market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the adrenocortical hormone API market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the adrenocortical hormone API market by type (prednisone series, dexamethasone series, betamethasone series, hydrocortisone series, and others), application (injectable drug, oral drug, for external use drug, and inhalation drug), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Adrenocortical Hormone API Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Adrenocortical Hormone API Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Adrenocortical Hormone API Market by Type
  • 3.3.1: Prednisone Series
  • 3.3.2: Dexamethasone Series
  • 3.3.3: Betamethasone Series
  • 3.3.4: Hydrocortisone Series
  • 3.3.5: Others
• 3.4: Global Adrenocortical Hormone API Market by Application
  • 3.4.1: Injectable Drug
  • 3.4.2: Oral Drug
  • 3.4.3: For External Use Drug
  • 3.4.4: Inhalation Drug

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Adrenocortical Hormone API Market by Region
• 4.2: North American Adrenocortical Hormone API Market
  • 4.2.1: North American Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
  • 4.2.2: North American Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
• 4.3: European Adrenocortical Hormone API Market
  • 4.3.1: European Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
  • 4.3.2: European Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
• 4.4: APAC Adrenocortical Hormone API Market
  • 4.4.1: APAC Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
  • 4.4.2: APAC Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
• 4.5: ROW Adrenocortical Hormone API Market
  • 4.5.1: ROW Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
  • 4.5.2: ROW Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Adrenocortical Hormone API Market by Type
  • 6.1.2: Growth Opportunities for the Global Adrenocortical Hormone API Market by Application
  • 6.1.3: Growth Opportunities for the Global Adrenocortical Hormone API Market by Region
• 6.2: Emerging Trends in the Global Adrenocortical Hormone API Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Adrenocortical Hormone API Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Adrenocortical Hormone API Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Pfizer CentreOne
• 7.2: EuroAPI
• 7.3: GlaxoSmithKline
• 7.4: Teva Pharmaceutical Industries
• 7.5: Hovione
• 7.6: Axplora
• 7.7: Steroid Spa
• 7.8: Avik Pharmaceutical
• 7.9: Anuh Pharma
• 7.10: Symbiotec Pharmalab